Dpc4 transcriptional activation and dysfunction in cancer cells

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4592-4597

  Le Dai, Jia ^a   Turnacioglu, Kenan K ^a   Schutte, Mieke ^a   Sugar, Avrahom Y ^a   Kern, Scott E ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; DNA SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REPORTER GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

DNA; DNA-BINDING PROTEINS; HUMANS; MUTATION; NEOPLASMS; SMAD4 PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0000128027     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
2. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor-suppressor gene at 18q21.1. Science (Washington DC), 271: 350-353, 1996.
3. Schutte, M., Hruban, R. H., Hedrick, L., Molnar'Nadasdy, G., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawro, H., Sidransky, D., Casero, R., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
4. Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. K. V., Markowitz, S. D., Hamilton, S. R., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet., 13: 343-346, 1996.
5. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADK2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
6. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., and Gelbart, W. M. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics, 139: 1347-1358, 1995.
7. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
8. Savage, C., Das, P., Finelli, A. L., Townsend, S. R., Sun, C-Y., Baird, S. E., and Padgett, R. W. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor β pathway components. Proc. Natl. Acad. Sci. USA, 93: 790-794, 1996.
9. Hoodless, P. A., Haerry, T., Abdollah, S., Stapleton, M., MB, O. C., Attisano, L., and Wrana, J. L. MADRI, a MAD-related protein that functions in BMP2 signaling pathways. Cell, 85: 489-500, 1996.
10. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S. E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell, 1: 611-617, 1998.
11. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J-M. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type I gene. EMBO J., 17: 3091-3100, 1998.
12. Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature (Lond.), 383: 832-836, 1996.
13. Zhang, Y., Feng, X., We, R., and Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature (Lond.), 383: 168-172, 1996.
14. Liu, F., Hata, A., Baker, J. C., Doody, J., Carcamo, J., Harland, R. M., and Massagué, J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature (Lond.), 381: 620-623, 1996.
15. Zhang, Y., Musci, T., and Derynck, R. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr. Biol., 7: 270-276, 1997.
16. Baldwin, R. L., Friess, H., Yokoyama, M., Lopez, M. E., Kobrin, M. S., Buchler, M. W., and Korc, M. Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int. J. Cancer, 67: 283-288, 1996.
17. WAF1 expression and growth inhibition by transforming growth factor β involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res., 57: 3929-3934, 1997.
18. Liu, F., Pouponnot, C., and Massagué, J. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev., 11: 3157-3167, 1997.
19. Yingling, J. M., Datto, M. B., Wong, C., Frederick, J. P., Liberati, N. T., and Wang, X-F. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol., 17: 7019-7028, 1997.
20. Kim, S. K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittleman, W. N., Hong, W. K., Lotan, R., and Mao, L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res., 56: 2519-2521, 1996.
21. Nagatake, M., Takagi, Y., Osada, N., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
22. Hata, A., Lo, R. S., Wotton, D., Lagna, G., and Massagué, J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature (Lond.), 388: 82-87, 1997.
23. Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., and Evan, G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23: 1686-1690, 1995.
24. Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Dai, J. L., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Targeted deletion of Smad4 shows it is required for transforming growth factor-β and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 95: 2412-2416, 1998.
25. Kim, J., Johnson, K., Chen, H. J., Carroll, S., and Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature (Lond.), 388: 304-308, 1997.
26. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. Regulation of the specific DNA binding function of p53. Cell, 71: 875-886, 1992.
27. Macias-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., and Wrana, J. L. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87: 1215-1224, 1996.
28. Das, P., Maduzia, L. L., Wang, H., Finelli, A. L., Cho, S-H., Smith, M. M., and Padgett, R. W. The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling. Development (Camb.), 125: 1519-1528, 1998.
29. Wisotzkey, R. G., Mehra, A., Sutherland, D. J., Dobens, L. L., Liu, X., Dohrmann, C., Attisano, L., and Raftery, L. A. Medea is a drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development (Camb.), 125: 1433-1445, 1998.
30. Shi, Y., Hata, A., Lo, R. S., Massagué, J., and Pavletich, N. P. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature (Lond.), 388: 87-93, 1997.
31. Riggins, G. J., Kinzler, K. W., Vogelstein, B., and Thiagalingam, S. Frequency of SMAD gene mutations in human cancers. Cancer Res., 57: 2578-2581, 1997.
32. Riggins, G. J., Thiagalingam, S., Goggins, M., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Normal SMAD2 gene in pancreatic cancer. NOGO, 1: 40, 1997.
33. Wieser, R., Wrana, J. L., and Massagué, J. GS domain mutations that constitutively activate TGFβ R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14: 2199-2208, 1995.
34. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G., and Whitman, M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature (Lond.), 389: 85-89, 1997.